Accessibility Menu
Kelyniam Global Stock Quote

Kelyniam Global (OTC: KLYG)

$0.14
(14.1%)
+0.02
Price as of February 9, 2026, 9:38 a.m. ET

KEY DATA POINTS

Current Price
$0.14
Daily Change
(14.1%) +$0.02
Day's Range
$0.13 - $0.14
Previous Close
$0.14
Open
$0.13
Beta
0.20
Volume
5
Average Volume
7,869
Market Cap
$1.8M
Market Cap / Employee
$0.14M
52wk Range
$0.05 - $0.34
Revenue
N/A
Gross Margin
0.46%
Dividend Yield
N/A
EPS
-$0.02
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Kelyniam Global Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
KLYG-55.62%-6.8%-1.4%-49%
S&P+12.9%+73.65%+11.66%+399%

Kelyniam Global Company Info

Kelyniam Global, Inc. operates as a medical device manufacturing company, which engages in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The company was founded on December 30, 2005 and is headquartered in Canton, CT.

News & Analysis

No results found

No news articles found for Kelyniam Global.

Financial Health

General

Q1 2025YOY Change
Revenue$624.91K-34.7%
Gross Profit$467.42K-36.5%
Gross Margin74.80%-2.1%
Market Cap$2.26M234.5%
Market Cap / Employee$251.34K0.0%
Employees90.0%
Net Income-$163.34K-284.8%
EBITDA-$128.95K-187.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q1 2025YOY Change
Net Cash$181.83K0.0%
Accounts Receivable$327.79K-17.6%
Inventory0-10.2%

Liabilities

Q1 2025YOY Change
Long Term Debt$277.80K-9.6%
Short Term Debt$263.30K52.3%

Ratios

Q1 2025YOY Change
Return On Assets-71.75%-70.7%
Return On Invested Capital-12.35%-4.5%

Cash Flow

Q1 2025YOY Change
Free Cash Flow-$102.15K-176.0%
Operating Free Cash Flow-$102.15K-176.0%

Valuation

MetricQ2 2024Q3 2024YoY Change
Price to Earnings15.2119.09-
Price to Book3.145.885.7310.09289.42%
Price to Sales0.701.232.512.98493.59%
Price to Tangible Book Value3.205.985.8010.37292.22%
Price to Free Cash Flow TTM16.5368.8177.8586.17-
Enterprise Value to EBITDA55.4864.23-10.12-72.01-628.49%
Free Cash Flow Yield6.0%1.5%1.3%1.2%-
Return on Equity23.3%31.9%-122.4%-163.7%6665.27%
Total Debt$561.43K$494.92K$418.39K$541.10K12.65%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.